Alpha DNA Investment Management’s Johnson & Johnson JNJ Stock Holding History

Alpha DNA Investment Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,706	Closed	-$970K	–	92
2024 Q4	$970K	Buy	6,706 +92	+1%	+$14.3K	0.37%	51
2024 Q3	$1.07M	Sell	6,614 -6,769	-51%	-$1.08M	0.4%	50
2024 Q2	$1.96M	Buy	13,383 +772	+6%	+$115K	0.76%	28
2024 Q1	$2M	Buy	12,611 +6,295	+100%	+$1M	0.74%	26
2023 Q4	$990K	Sell	6,316 -6,482	-51%	-$994K	0.39%	45
2023 Q3	$1.99M	Buy	12,798 +5	+0%	+$825	0.82%	20
2023 Q2	$2.12M	Buy	12,793 +10	+0.1%	+$1.61K	0.71%	20
2023 Q1	$1.98M	Buy	12,783 +7,424	+139%	+$1.2M	0.59%	19
2022 Q4	$947K	Buy	5,359 +328	+7%	+$56.6K	0.33%	135
2022 Q3	$822K	Buy	5,031 +3,875	+335%	+$656K	0.68%	40
2022 Q2	$205K	Buy	+1,156	New	+$206K	0.17%	113
2021 Q2	–	Sell	-835	Closed	-$137K	–	370
2021 Q1	$137K	Buy	835 +73	+10%	+$11.8K	0.16%	112
2020 Q4	$119K	Buy	+762	New	+$112K	0.13%	129

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alpha DNA Investment Management's JNJ Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 6,706 shares — an estimated $970K sold.

Alpha DNA Investment Management first reported a position in JNJ in Q4 2020 and held it in 13 quarters. The position peaked at $2.12M in Q2 2023. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

Alpha DNA Investment Management reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 6,706 Johnson & Johnson shares in Q1 2025, an estimated $970K.
Alpha DNA Investment Management first reported a position in Johnson & Johnson in Q4 2020 and held it in 13 quarters.
Alpha DNA Investment Management's Johnson & Johnson position peaked at $2.12M in Q2 2023.
4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.